Publication: Genes and metabolic pathway of sarcoidosis: Identification of key players and risk modifiers
| dc.contributor.author | Stjepanovic, Mihailo I. (55052044500) | |
| dc.contributor.author | Mihailovic-Vucinic, Violeta (13410407800) | |
| dc.contributor.author | Spasovski, Vesna (26655022200) | |
| dc.contributor.author | Milin-Lazovic, Jelena (57023980700) | |
| dc.contributor.author | Skodric-Trifunovic, Vesna (23499690800) | |
| dc.contributor.author | Stankovic, Sanja (7005216636) | |
| dc.contributor.author | Andjelkovic, Marina (57197728167) | |
| dc.contributor.author | Komazec, Jovana (57196477706) | |
| dc.contributor.author | Momcilovic, Ana (57222582752) | |
| dc.contributor.author | Santric-Milicevic, Milena (57211144346) | |
| dc.contributor.author | Pavlovic, Sonja (7006514877) | |
| dc.date.accessioned | 2025-06-12T15:29:00Z | |
| dc.date.available | 2025-06-12T15:29:00Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Introduction: Sarcoidosis is a rare multisystem granulomatous disease with unknown etiology. The interplay of vitamin D deficiency and genetic polymorphisms in genes coding for the proteins relevant for metabolism of vitamin D is an important, but unexplored area. The aim of this study was to investigate the association between single nucleotide polymorphisms (SNPs) in CYP2R1 (rs10741657), CYP27B1 (rs10877012), DBP (rs7041; rs4588), and VDR (rs2228570) genes and sarcoidosis, as well as the association between these SNPs and 25(OH)D levels in sarcoidosis patients. Material and methods: For that purpose we genotyped 86 sarcoidosis patients and 50 healthy controls using the PCR-RFLP method. Results: Subjects carrying the CC genotype of CYP27B1 rs10877012 have 10 times lower odds of suffering from sarcoidosis. Moreover, DBP rs4588 AA genotype was shown to be a susceptibility factor, where carriers of this genotype had eight times higher odds for developing sarcoidosis. In addition, the A allele of the DBP gene (rs4588) was associated with lower levels of 25(OH)D in sarcoidosis patients. Conclusions: These results suggest that patients with vitamin D deficiency should be regularly tested for genetic modifiers that are related to sarcoidosis in order to prevent development of serious forms of sarcoidosis. Copyright © 2018 Termedia & Banach | |
| dc.identifier.uri | https://doi.org/10.5114/aoms.2018.79682 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072179047&doi=10.5114%2faoms.2018.79682&partnerID=40&md5=7b75f0d0c76b2e7274ae62b20d7e51c4 | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/5795 | |
| dc.subject | 25(OH)D | |
| dc.subject | CYP27B1 | |
| dc.subject | CYP2R1 | |
| dc.subject | DBP | |
| dc.subject | Single nucleotide polymorphisms | |
| dc.subject | VDR | |
| dc.title | Genes and metabolic pathway of sarcoidosis: Identification of key players and risk modifiers | |
| dspace.entity.type | Publication |
